Chlorphenesin Carbamate

CHEMBL607710 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
245.7 g/mol
LogP
1.2
Phase
4

A centrally acting skeletal muscle relaxant related to mephenesin, historically used for the relief of acute musculoskeletal pain and discomfort. Its mechanism involves depression of polysynaptic reflexes in the spinal cord. It has largely fallen out of use in favor of other muscle relaxants with better-characterized safety profiles.

Molekularmasse

245,6600 g/mol

LogP

1,20

TPSA

81,80 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Wirkmechanismus

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)OCC(O)COc1ccc(Cl)cc1

InChI

InChI=1S/C10H12ClNO4/c11-7-1-3-9(4-2-7)15-5-8(13)6-16-10(12)14/h1-4,8,13H,5-6H2,(H2,12,14)

Molecular Formula

C10H12ClNO4

HBD / HBA

2 / 4

Rotierbare Bindungen

6

Schwere Atome

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A centrally acting skeletal muscle relaxant related to mephenesin, historically used for the relief of acute musculoskeletal pain and discomfort. Its mechanism involves depression of polysynaptic reflexes in the spinal cord. It has largely fallen out of use in favor of other muscle relaxants with better-characterized safety profiles.

Reduces skeletal muscle tone and spasm through central or peripheral mechanisms, typically by modulating spinal reflexes, enhancing inhibitory neurotransmission, or blocking neuromuscular transmission.

Yes, Chlorphenesin Carbamate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL607710. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2724. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.